Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Cash Flows from Operating Activities:
Net Income	$ 5,138	$ 3,001
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,629	1,480
Provision for bad debts	655	606
Stock issued for costs and expenses	384	553
Compensatory element of stock issuances	49	161
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivable(s)	(1,430)	(2,348)
Notes receivable	57	(283)
Costs and estimated earnings in excess of Billings on uncompleted contracts	(1,003)	(324)
Inventories	(936)	634
Prepaid expenses and other current assets	129	307
Other assets	108	(49)
Advances and notes to related medical practices		83
Increase (decrease) in operating liabilities, net:
Accounts payable	(164)	(830)
Other current liabilities	550	1,628
Customer advances	(1,537)	(121)
Billings in excess of costs and estimated earnings on uncompleted contracts	800	(2,555)
Other liabilities	(18)	22
Due to related medical practices	(7)	(298)
Income tax payable	(75)
Net cash provided by operating activities	4,329	1,667
Cash Flows from Investing Activities:
Sales of marketable securities	(2)	(2)
Purchases of property and equipment	(606)	(349)
Costs of capitalized software development		(67)
Cost of patents	(94)	(105)
Proceeds from non controlling interest	16	694
Sale to non controlling interest	10
Cash acquired from business combination		289
Net cash (used in) provided by investing activities	(676)	460
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(1,096)	(1,133)
Distributions to non controlling interests	(848)	(13)
Repayment of notes receivable from employee stockholders	43	74
Net cash used in financing activities	(1,901)	(1,072)
Net Increase in Cash and Cash Equivalents	1,752	1,055
Cash and Cash Equivalents – Beginning of Period	9,251	1,299
Cash and Cash Equivalents - End of Period	$ 11,003	$ 2,354